Daniele Mattei
Azienda Sanitaria Ospedaliera S.Croce e Carle Cuneo(IT)
Publications by Year
Research Areas
Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Acute Myeloid Leukemia Research, CAR-T cell therapy research
Most-Cited Works
- The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study.(2006)
- → Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)(2009)430 cited
- → Fungal Infections in Recipients of Hematopoietic Stem Cell Transplants: Results of the SEIFEM B-2004 Study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne(2007)413 cited
- → Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00(2010)271 cited
- → Clinical features of pulmonary arterial hypertension in patients receiving dasatinib(2015)121 cited
- → False-Positive Aspergillus Galactomannan Enzyme-Linked Immunosorbent Assay Results In Vivo during Amoxicillin-Clavulanic Acid Treatment(2004)98 cited
- → Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo(2008)98 cited
- → Reversible dasatinib-induced pulmonary arterial hypertension and right ventricle failure in a previously allografted CML patient(2008)96 cited
- → Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome(2016)87 cited
- → Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913(2020)80 cited